
Researchers at Yale School of Medicine have discovered a new drug compound that reverses the brain deficits of Alzheimer’s disease in an animal model.
Their findings are published in the Aug. 5 issue of the journal PLoS Biology.
The compound, TC-2153, inhibits the negative effects of a protein called STtriatal-Enriched tyrosine Phosphatase (STEP), which is key to regulating learning and memory. These cognitive functions are impaired in Alzheimer’s.
“Decreasing STEP levels reversed the effects of Alzheimer’s disease in mice,” said lead author Paul Lombroso, M.D., professor in the Yale Child Study Center and in the Departments of Neurobiology and Psychiatry at Yale School of Medicine.
Lombroso and co-authors studied thousands of small molecules, searching for those that would inhibit STEP activity. Once identified, those STEP-inhibiting compounds were tested in brain cells to examine how effectively they could halt the effects of STEP. They examined the most promising compound in a mouse model of Alzheimer’s disease, and found a reversal of deficits in several cognitive exercises that gauged the animals’ ability to remember previously seen objects.
Read more . . .
The Latest on: Alzheimer’s drug
[google_news title=”” keyword=”Alzheimer’s drug” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alzheimer’s drug
- Hint of Alzheimer's Benefit Seen With GLP-1 Drugon July 30, 2024 at 6:25 am
ELAD is one of several trials looking at whether GLP-1 drugs can benefit neurodegenerative diseases. In two phase III studies -- EVOKE and EVOKE Plus -- the effects of the GLP-1 receptor agonist ...
- Ozempic-like weight loss drugs may protect against Alzheimer'son July 30, 2024 at 6:00 am
A weight loss drug similar to Ozempic appeared to slow cognitive decline in patients with mild Alzheimer’s disease, according to new research.
- Can Weight Loss Drugs Like Ozempic Protect Brains And Stave Off Alzheimer’s? New Research Suggests They Can.on July 30, 2024 at 5:16 am
An older drug in the same GLP-1 class as Ozempic, Wegovy, Mounjaro and Zepbound appeared to protect the brain from shrinking and stave off dementia and Alzheimer’s, researchers found.
- For Alzheimer’s patients, this Novo Nordisk GLP-1 drug slows cognitive decline, study findson July 30, 2024 at 4:02 am
New clinical-trial data provide powerful evidence that GLP-1 drugs widely taken for weight loss may also help protect against dementia.
- Can popular weight-loss drugs like Ozempic stave off Alzheimer's disease?on July 30, 2024 at 4:02 am
An Alzheimer’s study reported liraglutide appeared to slow cognitive decline compared to a placebo. Researchers plan more testing to confirm.
- Scientists say weight-loss drugs could protect our brains from dementia. Early results suggest they're onto something.on July 30, 2024 at 4:01 am
Patients with Alzheimer's who took a GLP-1 drug improved their memory scores and lost less of their brains.
- Ozempic predecessor suggests potential for GLP-1 drugs in Alzheimer’s in early trialon July 30, 2024 at 4:00 am
A small clinical trial suggests that drugs like Ozempic could potentially be used not just for diabetes and weight loss but to protect the brain, slowing the rate at which people with Alzheimer’s ...
- Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study sayson July 30, 2024 at 4:00 am
Liraglutide is sold under the brand names Saxenda and Victoza, and sales are declining as blockbuster GLP-1s Ozempic and Wegovy skyrocket in demand.
- Novo’s Diabetes Drug Shows Mixed Results in Alzheimer’s Diseaseon July 30, 2024 at 4:00 am
Novo Nordisk A/S’s diabetes drug Victoza yielded mixed results in a mid-stage study of Alzheimer’s disease, failing to meet its primary goal while showing hints that larger trials of similar drugs may ...
- Older GLP-1 drug may help protect brains of Alzheimer’s patients, early study suggestson July 30, 2024 at 4:00 am
A new study suggests that an older GLP-1 drug may help protect the brains of people with early Alzheimer’s disease, though more research is needed.
via Bing News